KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 105 filers reported holding KEROS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $80,300,383 | -21.5% | 1,757,120 | +13.7% | 0.00% | 0.0% |
| Q1 2024 | $102,329,179 | +79.7% | 1,545,758 | +7.9% | 0.00% | +100.0% |
| Q4 2023 | $56,944,074 | +27.0% | 1,432,195 | +1.8% | 0.00% | 0.0% |
| Q3 2023 | $44,837,021 | -5.7% | 1,406,431 | +18.8% | 0.00% | 0.0% |
| Q2 2023 | $47,564,239 | +6.3% | 1,183,779 | +12.9% | 0.00% | 0.0% |
| Q1 2023 | $44,752,247 | -10.8% | 1,048,062 | +0.3% | 0.00% | 0.0% |
| Q4 2022 | $50,196,267 | +47.2% | 1,045,320 | +15.3% | 0.00% | 0.0% |
| Q3 2022 | $34,105,000 | +60.0% | 906,574 | +17.5% | 0.00% | 0.0% |
| Q2 2022 | $21,320,000 | -46.8% | 771,618 | +4.8% | 0.00% | 0.0% |
| Q1 2022 | $40,056,000 | -6.7% | 736,593 | +0.4% | 0.00% | 0.0% |
| Q4 2021 | $42,930,000 | +52.9% | 733,720 | +3.4% | 0.00% | 0.0% |
| Q3 2021 | $28,078,000 | -1.1% | 709,761 | +6.2% | 0.00% | 0.0% |
| Q2 2021 | $28,378,000 | -23.5% | 668,203 | +10.9% | 0.00% | 0.0% |
| Q1 2021 | $37,092,000 | -11.2% | 602,646 | +1.8% | 0.00% | 0.0% |
| Q4 2020 | $41,778,000 | +262.4% | 592,255 | +98.1% | 0.00% | – |
| Q3 2020 | $11,529,000 | -1.6% | 298,931 | -4.3% | 0.00% | – |
| Q2 2020 | $11,719,000 | – | 312,407 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 292,833 | $17,134,000 | 5.65% |
| Deep Track Capital, LP | 1,300,000 | $76,063,000 | 5.37% |
| Octagon Capital Advisors LP | 340,214 | $19,906,000 | 3.87% |
| Opaleye Management Inc. | 265,750 | $15,549,000 | 3.30% |
| First Light Asset Management, LLC | 552,098 | $32,303,000 | 2.31% |
| Altium Capital Management LP | 116,000 | $6,787,000 | 1.87% |
| Nantahala Capital Management | 796,698 | $46,615,000 | 1.64% |
| Orbimed Advisors | 1,679,417 | $98,263,000 | 1.26% |
| Darwin Global Management, Ltd. | 111,500 | $6,524,000 | 1.00% |
| Parkman Healthcare Partners LLC | 69,861 | $4,088,000 | 0.90% |